Tofacitinib in the treatment of cardiac sarcoidosis: towards steroid-sparing disease management.

Open Heart · 2026 · PMC13052810 · PMID 41916671

Europe PMC DOI

hedged sentence

0.1160

closest p · 2.3× alpha

0.1160

boldest claim

The sentences

did not reach statistical significancep=0.116not close (p > 0.1)

Across all patients (Nr 1–8), the mean neopterin level decreased from 2.52±0.846 ng/mL before treatment to 1.94±0.705 ng/mL after treatment; however, this reduction did not reach statistical significance (p=0.116).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.